Mao, Can Van Araujo, Mariana F. P. Nishimaru, Hiroshi Matsumoto, Jumpei Tran, Ahn Hai Hori, Etsuro Ono, Taketoshi and Nishijo, Hisao 2017. Pregenual Anterior Cingulate Gyrus Involvement in Spontaneous Social Interactions in Primates—Evidence from Behavioral, Pharmacological, Neuropsychiatric, and Neurophysiological Findings. Frontiers in Neuroscience, Vol. 11,
Alves, Lívia M. Castro, Ana C. H. Oliveira, Samuel M. Júnior, Luiz C. O. Goulart, Luiz R. Bonetti, Ana M. Machado, Antonio E. H. Ueira-Vieira, Carlos Madurro, João M. and Brito-Madurro, Ana G. 2016. Development of a mimetic system for electrochemical detection of glutamate. Journal of Solid State Electrochemistry, Vol. 20, Issue. 9, p. 2479.
Aquila, Ralph and Citrome, Leslie 2015. Cognitive impairment in schizophrenia: the great unmet need. CNS Spectrums, Vol. 20, Issue. S1, p. 32.
Badawy, Abdulla A-B and Dougherty, Donald M 2015. Standardization of formulations for the acute amino acid depletion and loading tests. Journal of Psychopharmacology, Vol. 29, Issue. 4, p. 363.
Sanders, Talia Liu, Yi-Ming and Tchounwou, Paul B. 2015. Cytotoxic, genotoxic, and neurotoxic effects of Mg, Pb, and Fe on pheochromocytoma (PC-12) cells. Environmental Toxicology, Vol. 30, Issue. 12, p. 1445.
Flores, Alex F. C. Piovesan, Luciana A. Pizzuti, Lucas Flores, Darlene C. Malavolta, Juliana L. and Martins, Marcos A. P. 2014. From Renewable Levulinic Acid to a Diversity of 3-(Azol-3-yl)Propanoates. Journal of Heterocyclic Chemistry, Vol. 51, Issue. 3, p. 733.
Lee, Sheng-Yu Chen, Shiou-Lan Chang, Yun-Hsuan Chen, Po See Huang, San-Yuan Tzeng, Nian-Sheng Wang, Yu-Shan Wang, Liang-Jen Lee, I. Hui Yeh, Tzung Lieh Yang, Yen Kuang Lu, Ru-Band and Hong, Jau-Shyong 2013. Add-on memantine to valproate treatment increased HDL-C in bipolar II disorder. Journal of Psychiatric Research, Vol. 47, Issue. 10, p. 1343.
Malhi, Gin S. Tanious, Michelle Das, Pritha Coulston, Carissa M. and Berk, Michael 2013. Potential Mechanisms of Action of Lithium in Bipolar Disorder. CNS Drugs, Vol. 27, Issue. 2, p. 135.
Voineskos, Daphne Rogasch, Nigel C Rajji, Tarek K Fitzgerald, Paul B and Daskalakis, Zafiris J 2013. A Review of Evidence Linking Disrupted Neural Plasticity to Schizophrenia. The Canadian Journal of Psychiatry, Vol. 58, Issue. 2, p. 86.
Sani, Gabriele Serra, Giulia Kotzalidis, Giorgio D. Romano, Silvia Tamorri, Stefano M. Manfredi, Giovanni Caloro, Matteo Telesforo, C. Ludovica Caltagirone, Saverio S. Panaccione, Isabella Simonetti, Alessio Demontis, Francesca Serra, Gino and Girardi, Paolo 2012. The Role of Memantine in the Treatment of Psychiatric Disorders Other Than the Dementias. CNS Drugs, Vol. 26, Issue. 8, p. 663.
Lee, Jung Goo Lee, Sae Woom Lee, Bong Ju Park, Sung Woo Kim, Gyung Mee and Kim, Young Hoon 2012. Adjunctive Memantine Therapy for Cognitive Impairment in Chronic Schizophrenia: A Placebo-Controlled Pilot Study. Psychiatry Investigation, Vol. 9, Issue. 2, p. 166.
Ardjmand, Abolfazl Rezayof, Ameneh and Zarrindast, Mohammad-Reza 2011. Involvement of central amygdala NMDA receptor mechanism in morphine state-dependent memory retrieval. Neuroscience Research, Vol. 69, Issue. 1, p. 25.
Fingelkurts, Alexander A. and Fingelkurts, Andrew A. 2009. Is our brain hardwired to produce God, or is our brain hardwired to perceive God? A systematic review on the role of the brain in mediating religious experience. Cognitive Processing, Vol. 10, Issue. 4, p. 293.
Keck, Paul E. Hsu, Hai-An Papadakis, Kelly and Russo, John 2009. Memantine Efficacy and Safety in Patients With Acute Mania Associated With Bipolar I Disorder. Clinical Neuropharmacology, Vol. 32, Issue. 4, p. 199.
Krivoy, Amir Weizman, Abraham Laor, Lucian Hellinger, Nurit Zemishlany, Zvi and Fischel, Tsvi 2008. Addition of memantine to antipsychotic treatment in schizophrenia inpatients with residual symptoms: A preliminary study. European Neuropsychopharmacology, Vol. 18, Issue. 2, p. 117.
Mao, C.V. Hori, E. Maior, R. Ono, T. and Nishijo, H. 2008. A Primate Model of Schizophrenia Using Chronic PCP Treatment. Reviews in the Neurosciences, Vol. 19, Issue. 2-3,
Li, Weidong and Neugebauer, Volker 2004. Block of NMDA and non-NMDA receptor activation results in reduced background and evoked activity of central amygdala neurons in a model of arthritic pain. Pain, Vol. 110, Issue. 1, p. 112.
Findlay, David J and Connelly, Peter J 2003. Memantine (Ebixa®) in the later stages of dementia. Hospital Medicine, Vol. 64, Issue. 11, p. 654.
Most of the excitatory neurotransmission in the central nervous system (CNS) is mediated by the endogenous excitatory amino acids (EAAs) glutamate, aspartate and homocysteine. Most of the endogenous inhibitory neurotransmission is mediated by gamma-aminobutyric acid (GABA). EAAs modulate the firing of almost all neurons in the CNS, as excitatory neurotransmission can result in both neuronal inhibition and excitation. The glutamate system is the best characterised of the EAA systems (Box 1).
Email your librarian or administrator to recommend adding this journal to your organisation's collection.
Full text views reflects the number of PDF downloads, PDFs sent to Google Drive, Dropbox and Kindle and HTML full text views.
* Views captured on Cambridge Core between 2nd January 2018 - 21st March 2018. This data will be updated every 24 hours.